novo nordisk glp-1 receptor agonists weight management diabetes treatments obesity drugs cleared of suicide warning Novo Nordisk to launch Ozempic

The evidence reveals significant heterogeneity in the effects of GLP-1RAs across different cancer types

SURMOUNT-4 examined what happens when you stop tirzepatide

Beyond Weight Loss: Total Body Health The choice of medication often depends on your existing health profile

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior

Triple Hormone Receptor Agonist Retatrutide for Metabolic dysfunction-associated Steatotic Liver Disease: a Randomized Phase 2a Trial

3 Results 3.1 Mechanism of action and clinical impact 3.1.1 Mechanism of action of SGLT2 inhibitors Phlorizin, a botanical extract, is a non-specific inhibitor of sodium-glucose transporter proteins